Bristol Myers Squibb (BMS) has shared positive results from a late stage of Opdivo (nivolumab) plus Yervoy (ipilimumab) in a ...

AstraZeneca (AZ) and Merck’s – known as MSD outside the US and Canada – Lynparza (olaparib) has been recommended by the ...

GSK and the Global Coalition on Aging (GCOA) have announced a new report from the IQVIA Institute of Human Data Science ...

It shows that ‘HCP insight (needs and behaviour)’ is the industry’s number one strategic HCP engagement priority for the year ...

Researchers from Stanford Medicine at Stanford University have revealed a new, simple way of studying organ ageing using a blood test to predict individuals’ risk of diseases associated with organ ...

Cancer Research UK (CRUK), its innovation unit, Cancer Research Horizons, and Guardant Health have announced a collaboration ...

AstraZeneca (AZ) and Absci have entered into a collaboration agreement worth up to $247m to develop an artificial ...

Sanofi and artificial intelligence (AI) specialist Aqemia have entered into a multi-year research collaboration worth $140m ...

Boehringer Ingelheim and IBM have announced a partnership aimed at advancing generative artificial intelligence (AI) and ...

The European Commission (EC) has approved UCB’s Zilbrysq (zilucoplan) as an add-on therapy for certain patients with ...

Novartis’ Fabhalta (iptacopan) has been approved by the US Food and Drug Administration (FDA) as the first oral monotherapy ...

Pfizer’s Abrysvo has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) as the first respiratory ...